I. Introduction
Thalassemia are the most common genetic disorder worldwide. In India, over 40 million people carry genes for beta thalassemia. 1 The thalassemias are heterogeneous group of disorders with genetically determined reduction in the rate of synthesis of one or more types of globin chain of haemoglobin (alpha or beta chain). 2 In India, the diagnosis of thalassemia is often delayed due to lack of awareness regarding disease and the lack of facilities for diagnosis. The high mortality and morbidity in patients of thalassemia is the consequence of iron overload. Iron overload occurs mainly due to repeated blood transfusions and other factors like increased gastrointestinal absorption, ineffective erythropoiesis, lack of physiologic mechanism to excrete excess iron. Cardiac complications are the major cause of mortality in thalassemia patients. After about 10 years of transfusion, cardiac dysfunction secondary to haemosiderosis begins. 3 Free iron damages cardiocytes inducing lipid peroxidation and lysosomal rupture. Eventually, most patients not receiving adequate iron chelation therapy develop cardiomyopathy, cardiac failure or arrhythmias secondary to myocardial haemosiderosis. 4 
II. Methodology
This study was done on 60 confirmed cases of thalassemia diagnosed on the basis of HPLC (High Performance Liquid Chromatography) of age group 8 months to 12 years attending inpatient and outpatient ward, Department of Paediatrics and Neonatology, Rajendra Institute of Medical Sciences, Ranchi., during the period of February 2015 to April 2016 for the assessment of their cardiac function.
The following information were taken from each patient: name, age, sex, religion, region, age at the time of diagnosis of thalassemia, total units of blood transfusions, whether the patient is on iron chelators, if yes, duration of therapy. Physical examination of the patient included general examination and cardiovascular system examination. Laboratory tests included pre and post transfusional haemoglobin, serum iron and ferritin level by chemiluminescence method and ECG. Patients having severe systemic illness and congenital heart disease were excluded from this study.
III. Results
In this study, out of 60 patients of thalassemia, majority of the patients (70%) were males. Patients age ranged from 8 months to 12 years. Majority of patients were less than 5 years (56.6%). Among 60 thalassemic children, the youngest case was diagnosed at 4 months of age and oldest at 18 months of age and mean age of 
Fig 1: Ecg Changes
In patients with ECG changes , 24 children (40%) had tachycardia, 3 patients (5%) had bradycardia , 14 children (23.3%) had arrhythmia, 12 patients (20%) had Left Ventricular Hypertrophy (LVH) , 7 patients (11.6%) with ST-T wave changes and 2 patients (3.3%) had conduction block (1 st degree heart block). Comparative study between patients with normal ECG and with ECG changes present showed statistically significant difference (p<0.05) in relation to mean age , total units of BT, serum ferritin level which shows that ECG changes appear to be increasing with age, more units of BT, S. ferritin level. Though there was difference in the S. iron level between the two groups but it was not statistically significant. (p>0.05).
IV. Discussion
In the present study, minimum age of diagnosis was 4 months and maximum age as 18 months, the mean being around 7 months. This implies that thalassemia major patients present symptoms early in childhood, an early as 3 to 6 months with progressive pallor being the most common manifestation. 9 reported that some of thalassemic patients reported pericarditis after the the age of 10 years.
Anna Ramazzatti et al 2008 5 found most common ECG changes being T wave inversion(27%), Right bundle branch block(RBBB) in 12%, flat T wave in 7% of the patients.
Pepe a et al 2009 10 reported the most common ECG changes being T-wave inversion, flat T waves and RBBB.
In the present study, out of 60 thalassemics, 41 patients (68.3%) were on chelation therapy, all were on single oral iron chelator, deferasirox and 19 patients (31.6%) were not on chelation therapy. In the age group <5 years, iron overload in these patients as suggested by serum iron and ferritin level is less owing to less duration of illness and total number of blood transfusions. Serum iron and ferritin level in patients on iron chelators appears to be rising with age. This finding suggests that though the patients are on oral iron chelators, but serum iron and ferritin level is increasing due to increasing number of blood transfusions which contributes to iron overload in thalassemic patients and single oral iron chelators is not effective in reducing iron overload in these patients.
In the present study, comparison was made between the patients with ECG changes and those without ECG changes. It was found that there was statistically significant difference between the two groups in relation to mean age, total units of blood transfusions, serum ferritin level. There was definitive positive correlation with serum ferritin level showing ECG changes appears due to myocardial siderosis secondary to iron overload. However, there was difference related to serum iron in the two groups, but not statistically significant. The above findings are suggestive of the fact that cardiac complications in thalassemia major increases with increasing total units of blood transfusions with increasing age. These blood transfusions combined with increased gastrointestinal absorption contributing to iron overload and myocardial iron deposition leading to cardiac dysfunction. Cardiac monitoring of the patients at regular intervals is required. ECG owing to its low cost can be used in areas where there is high prevalence of thalassemia and limited resources.
V. Conclusion
Thalassemia syndromes are important cause of morbidity and mortality in children. Though cardiac dysfunction secondary to iron overload in thalassemic patients may start early in life, clinical signs are not observed in most patients. Regular follow up for early detection and therefore timely treatment of such complications could improve the quality of life of these patients. There was strong association between high serum ferritin level and cardiac dysfunction. This stresses the need for intensive iron chelation therapy to be individually monitored to provide normal iron balance which should be sufficient to avoid cardiotoxicity and other associated complications due to iron overload.
